C136H219F3N22O8 — CID 160519221
1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine (PubChem CID 160519221) has the molecular formula C136H219F3N22O8 and a molecular weight of 2347.39 g/mol. Its IUPAC name is 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine.
| Compound Name | 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine |
|---|---|
| PubChem CID | 160519221 |
| Molecular Formula | C136H219F3N22O8 |
| Molecular Weight | 2347.39 g/mol |
| Exact Mass | 2345.74 |
| IUPAC Name | 1-[4-[[4-tert-butyl-6-[2-(dimethylamino)ethoxy]-2-pyridinyl]methyl]piperidin-1-yl]ethanone;4-tert-butyl-6-[(4-methoxycyclohexyl)methyl]pyrimidine;1-[4-[(4-tert-butyl-6-methoxy-2-pyridinyl)methyl]piperidin-1-yl]ethanone;1-[3-[(5-tert-butylpyridazin-3-yl)methyl]azetidin-1-yl]ethanone;N-[4-[(6-tert-butylpyrimidin-4-yl)methyl]cyclohexyl]-N-methylacetamide;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-ethyl-N-methylcyclohexan-1-amine;4-[(6-tert-butylpyrimidin-4-yl)methyl]-N-methylcyclohexan-1-amine;5-tert-butyl-3-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]oxypyridazine |
| SMILES | CC(=O)N(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CC(=O)N1CC(Cc2cc(C(C)(C)C)cnn2)C1.CC(=O)N1CCC(Cc2cc(C(C)(C)C)cc(OCCN(C)C)n2)CC1.CC(C)(C)c1cnnc(OC2CCN(CC(F)(F)F)CC2)c1.CCN(C)C1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.CNC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COC1CCC(Cc2cc(C(C)(C)C)ncn2)CC1.COc1cc(C(C)(C)C)cc(CC2CCN(C(C)=O)CC2)n1 |
| InChI | InChI=1S/C21H35N3O2.C18H29N3O.C18H31N3.C18H28N2O2.C16H27N3.C16H26N2O.C15H22F3N3O.C14H21N3O/c1-16(25)24-9-7-17(8-10-24)13-19-14-18(21(2,3)4)15-20(22-19)26-12-11-23(5)6;1-13(22)21(5)16-8-6-14(7-9-16)10-15-11-17(18(2,3)4)20-12-19-15;1-6-21(5)16-9-7-14(8-10-16)11-15-12-17(18(2,3)4)20-13-19-15;1-13(21)20-8-6-14(7-9-20)10-16-11-15(18(2,3)4)12-17(19-16)22-5;1-16(2,3)15-10-14(18-11-19-15)9-12-5-7-13(17-4)8-6-12;1-16(2,3)15-10-13(17-11-18-15)9-12-5-7-14(19-4)8-6-12;1-14(2,3)11-8-13(20-19-9-11)22-12-4-6-21(7-5-12)10-15(16,17)18;1-10(18)17-8-11(9-17)5-13-6-12(7-15-16-13)14(2,3)4/h14-15,17H,7-13H2,1-6H3;11-12,14,16H,6-10H2,1-5H3;12-14,16H,6-11H2,1-5H3;11-12,14H,6-10H2,1-5H3;10-13,17H,5-9H2,1-4H3;10-12,14H,5-9H2,1-4H3;8-9,12H,4-7,10H2,1-3H3;6-7,11H,5,8-9H2,1-4H3 |
| InChIKey | QUBBDCXMGLEBRJ-UHFFFAOYSA-N |
| XLogP | 25.08 |
| TPSA | 320.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 169 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2347.39 |
| LogP ≤ 5 | 25.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 26 |